Visual Acuity

In this Healio Video Perspective from the ASRS meeting, Diana V. Do, MD, FASRS, of Byers Eye Institute discusses data from the PHOTON trial investigating aflibercept 8 mg and aflibercept 2 mg for the treatment of diabetic macular edema.

CooperVision has announced the U.S. launch of its new Clariti 1 Day Multifocal 3 Add contact lenses, designed to provide all-day comfort, ease of fit and optimal visual acuity at all distances for all levels of presbyopia.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Reenie McCarthy of Stealth BioTherapeutics discusses a phase 3 clinical trial of elamipretide in dry age-related macular degeneration.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, of Sierra Eye Associates in Nevada, presents 3-month data on AVD-104 for geographic atrophy.

Digital health company Luminopia Inc. announced real-world data from the Patients Using Prescription Luminopia Registry, which demonstrated the efficacy of its binocular, virtual reality-based medical device for children with amblyopia.

SEATTLE — A study on progression of dry age-related macular degeneration found that smoking did not affect the likelihood of developing wet AMD, but smokers had worse visual acuity than nonsmokers.

Verana Health launched a real-world dataset for patients with uveitic macular edema, according to a press release.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, George O. Waring IV, MD, FACS, discusses 1-year data for the modular shape-changing OmniVu IOL system from Atia Vision.

Wellness company HealthyCell has announced the launch of Eye Health, the newest supplement in the company’s MicroGel product line, which is designed to promote visual acuity, protect against oxidative stress and support retinal health.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilsher S. Dhoot, MD, discusses 52-week phase 1 data for Axpaxli for the treatment of neovascular age-related macular degeneration.